K192095

Substantially Equivalent

CAPI 3 Immunotyping, Capillarys 3 Tera

Applicant: Sebia
Product code: CFF
Advisory panel: Immunology
Date received: 2019-08-05
Decision date: 2019-11-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Norcross, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.